Normal view MARC view ISBD view

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer.

Fraser, Michael

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer. [electronic resource] - Urologic oncology Feb 2015 - 85-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

ISSN: 1873-2496

Standard No.: 10.1016/j.urolonc.2013.10.020 doi

Subjects--Topical Terms:
Genomics--methods
Humans
Male
Precision Medicine--methods
Prognosis
Prostatic Neoplasms--genetics
Prostatic Neoplasms, Castration-Resistant--genetics

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)